What about studies reviewed by a non-UW-Madison IRB?

Last updated: 3/17/2020

If you have a study that has been reviewed by an external IRB (e.g., WIRB or Advarra, another academic institution), we advise the following:

  • Study teams should follow the UW’s COVID-19 guidance unless provided with more stringent guidance from the reviewing IRB.
  • Study teams should consult with the lead study team, sponsor, and/or the reviewing IRB to determine whether anything needs to be reported about changes to study activities at UW-Madison to the reviewing IRB.
  • Study teams do NOT need to submit any COVID-19-related changes to cede applications in ARROW unless required to do so by the reviewing IRB.
  • Guidance for studies reviewed by the NCI CIRB can be found here.

If you have questions about the above, please contact the Reliance and Navigation Team (RELIANT; irbreliance@wisc.edu) for assistance.

Keywords:external IRB, coronavirus, COVID-19, reliant, reliance   Doc ID:99031
Owner:Monica E.Group:Health Sciences IRBs
Created:2020-03-17 20:28 CDTUpdated:2020-03-17 20:28 CDT
Sites:Health Sciences IRBs
Feedback:  0   0